Skip to main content
. 2019 Aug;69(4):311–320. doi: 10.30802/AALAS-CM-18-000089

Table 3.

Percentage (%) of nontyped MSSA isolates (n = 15) susceptible to antimicrobials

Susceptible Intermediate Resistant
Enrofloxacin 87 0 13
Ampicillin 100 0 0
Ceftriaxone 100 0 0
Chloramphenicol 93 7 0
Clindamycin 100 0 0
Erythromycin 100 0 0
Gentamicin 100 0 0
Oxacillin 100 0 0
Penicillin 100 0 0
Rifampin 100 0 0
Tetracycline 100 0 0
TMS 100 0 0
Vancomycin 100 0 0